India · Delayed Price · Currency is INR SMS Pharmaceuticals Statistics
Total Valuation
NSE:SMSPHARMA has a market cap or net worth of INR 48.98 billion. The enterprise value is 52.11 billion.
| Market Cap | 48.98B |
| Enterprise Value | 52.11B |
Important Dates
The last earnings date was Wednesday, November 4, 2026.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Sep 22, 2026 |
Share Statistics
NSE:SMSPHARMA has 93.65 million shares outstanding. The number of shares has increased by 2.93% in one year.
| Current Share Class | 93.65M |
| Shares Outstanding | 93.65M |
| Shares Change (YoY) | +2.93% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 65.27% |
| Owned by Institutions (%) | 2.91% |
| Float | 22.40M |
Valuation Ratios
The trailing PE ratio is 41.87.
| PE Ratio | 41.87 |
| Forward PE | n/a |
| PS Ratio | 4.93 |
| PB Ratio | 5.70 |
| P/TBV Ratio | 5.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 39.18 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 43.78 |
| EV / Sales | 5.25 |
| EV / EBITDA | 24.56 |
| EV / EBIT | 30.46 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.67 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 1.79 |
| Debt / FCF | n/a |
| Interest Coverage | 7.12 |
Financial Efficiency
Return on equity (ROE) is 14.88% and return on invested capital (ROIC) is 10.60%.
| Return on Equity (ROE) | 14.88% |
| Return on Assets (ROA) | 7.08% |
| Return on Invested Capital (ROIC) | 10.60% |
| Return on Capital Employed (ROCE) | 14.77% |
| Weighted Average Cost of Capital (WACC) | 5.38% |
| Revenue Per Employee | 6.03M |
| Profits Per Employee | 723,237 |
| Employee Count | 1,617 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.81 |
Taxes
In the past 12 months, NSE:SMSPHARMA has paid 343.26 million in taxes.
| Income Tax | 343.26M |
| Effective Tax Rate | 22.69% |
Stock Price Statistics
The stock price has increased by +77.31% in the last 52 weeks. The beta is 0.21, so NSE:SMSPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | +77.31% |
| 50-Day Moving Average | 450.75 |
| 200-Day Moving Average | 396.33 |
| Relative Strength Index (RSI) | 64.61 |
| Average Volume (20 Days) | 719,912 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SMSPHARMA had revenue of INR 9.74 billion and earned 1.17 billion in profits. Earnings per share was 12.49.
| Revenue | 9.74B |
| Gross Profit | 3.45B |
| Operating Income | 1.55B |
| Pretax Income | 1.51B |
| Net Income | 1.17B |
| EBITDA | 1.95B |
| EBIT | 1.55B |
| Earnings Per Share (EPS) | 12.49 |
Balance Sheet
The company has 363.13 million in cash and 3.49 billion in debt, with a net cash position of -3.13 billion or -33.44 per share.
| Cash & Cash Equivalents | 363.13M |
| Total Debt | 3.49B |
| Net Cash | -3.13B |
| Net Cash Per Share | -33.44 |
| Equity (Book Value) | 8.43B |
| Book Value Per Share | 90.08 |
| Working Capital | 2.75B |
Cash Flow
In the last 12 months, operating cash flow was 1.23 billion and capital expenditures -1.87 billion, giving a free cash flow of -641.15 million.
| Operating Cash Flow | 1.23B |
| Capital Expenditures | -1.87B |
| Depreciation & Amortization | 404.19M |
| Net Borrowing | 249.49M |
| Free Cash Flow | -641.15M |
| FCF Per Share | -6.85 |
Margins
Gross margin is 35.46%, with operating and profit margins of 15.91% and 12.00%.
| Gross Margin | 35.46% |
| Operating Margin | 15.91% |
| Pretax Margin | 15.53% |
| Profit Margin | 12.00% |
| EBITDA Margin | 20.06% |
| EBIT Margin | 15.91% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.08%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 0.08% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.20% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.93% |
| Shareholder Yield | -2.85% |
| Earnings Yield | 2.39% |
| FCF Yield | -1.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on December 17, 2015. It was a forward split with a ratio of 10.
| Last Split Date | Dec 17, 2015 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |